News & Updates
Filter by Specialty:
Cannabidiol shots safe but of no benefit in drug-resistant focal epilepsy
In the treatment of patients with drug-resistant focal epilepsy, transdermally administered cannabidiol is well tolerated but is not superior to placebo in terms of reducing seizure frequency, according to a study.
Cannabidiol shots safe but of no benefit in drug-resistant focal epilepsy
18 Jul 2022
Resmetirom demos potential in NASH
Safety analysis of the phase III MAESTRO-NAFLD-1 trial presented at ILC 2022 demonstrated the potential of resmetirom as a treatment for patients with non-alcoholic steatohepatitis (NASH) who have liver fibrosis.
Resmetirom demos potential in NASH
18 Jul 2022
Electroacupuncture helps fight insomnia in patients with depression
For patients with depression who struggle to fall asleep, electroacupuncture can help with getting a better night’s sleep, with sustained effects, as shown in a study.
Electroacupuncture helps fight insomnia in patients with depression
18 Jul 2022
Nonexercise estimated cardiorespiratory fitness tied to reduced hypertension risk
Adults with good cardiorespiratory fitness, estimated by a nonexercise algorithm, have a lower risk of developing hypertension, suggests a study.
Nonexercise estimated cardiorespiratory fitness tied to reduced hypertension risk
18 Jul 2022
Weekly dose-dense CT does not confer survival benefit for ovarian cancer patients
In the final analysis of the phase III ICON8* study, a weekly dose-dense chemotherapy (CT) regimen comprising paclitaxel and carboplatin did not improve survival outcomes in women with epithelial ovarian cancer** compared with the standard first-line (1L) paclitaxel-carboplatin regimen given once every 3 weeks (Q3W).
